Start for free
Start for free
MV

Magnetic Ventures

North America, California, United States, San Francisco

Description

Magnetic Ventures is an early stage venture capital firm investing at the intersection of life science and technology.

Investor Profile

Magnetic Ventures has made 16 investments, with 2 in the past 12 months and 31% as lead.

Stage Focus

  • Seed (31%)
  • Series B (31%)
  • Series A (31%)
  • Series C (6%)

Country Focus

  • United States (69%)
  • United Kingdom (13%)
  • Canada (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Genetics
  • Life Science
  • Wellness
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Magnetic Ventures frequently co-invest with?

Bristol-Myers Squibb
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
Amplitude Venture Capital
Amplitude Venture Capital
North America, Quebec, Canada, Montréal
Co-Investments: 2
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Lux Capital
Lux Capital
North America, New York, United States, New York
Co-Investments: 2
DCVC
DCVC
North America, California, United States, San Francisco
Co-Investments: 2
ARK Investment Management
ARK Investment Management
North America, New York, United States, New York
Co-Investments: 1
True Ventures
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4
Khosla Ventures
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 4

Which angels does Magnetic Ventures often collaborate with?

JE
John Evans
North America, New York, United States, New York
Shared Deals: 1
JM
John Maraganore
North America, Massachusetts, United States, Boston
Shared Deals: 1
MP
Mark P. Stevenson
Europe, United Kingdom
Shared Deals: 1
Victor Oladipo
Shared Deals: 1
PS
Peer Schatz
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Shared Deals: 1
JM
Jonathan Milner
North America, Massachusetts, United States, Cambridge
Shared Deals: 2

What are some of recent deals done by Magnetic Ventures?

Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.

Biotechnology
SeedFeb 12, 2025
Amount Raised: $9,000,000
Weave

New York, New York, United States

Weave provides an artificial intelligence collaboration platform for biomedicine.

Artificial Intelligence (AI)BiotechnologyLife Science
SeedMay 30, 2024
Amount Raised: $10,000,000
Relation Therapeutics

London, England, United Kingdom

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

BiotechnologyGeneticsHealth CareMedical
SeedMar 14, 2024
Amount Raised: $35,000,000
Paradigm

New York, New York, United States

Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.

Health CareHealth DiagnosticsHospitalLife Science
Series AJan 25, 2023
Amount Raised: $203,000,000
Relation Therapeutics

London, England, United Kingdom

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

BiotechnologyGeneticsHealth CareMedical
SeedJun 9, 2022
Amount Raised: $25,000,000
Transition Bio

Cambridge, Massachusetts, United States

Transition Bio provides condensate technology for drug discovery and diagnostics.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series AJun 2, 2022
Amount Raised: $50,000,000
Spotlight Therapeutics

Hayward, California, United States

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BMar 22, 2022
Amount Raised: $36,500,000
Deep Genomics

Toronto, Ontario, Canada

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

Artificial Intelligence (AI)BiotechnologyGeneticsTherapeutics
Series CJul 28, 2021
Amount Raised: $180,000,000
HiberCell

New York, New York, United States

HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BMay 19, 2021
Amount Raised: $67,400,000
AppliedVR

Van Nuys, California, United States

AppliedVR offers virtual reality-based therapeutic treatments that address the complexity of chronic pain.

Enterprise SoftwareHealth CareVirtual RealityWellness
Series AMar 23, 2021
Amount Raised: $29,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator